Logo image of CMBT

CMB TECH NV (CMBT) Stock Fundamental Analysis

NYSE:CMBT - BE0003816338 - Common Stock

8.435 USD
+0.53 (+6.64%)
Last: 8/28/2025, 2:36:08 PM
Fundamental Rating

4

Taking everything into account, CMBT scores 4 out of 10 in our fundamental rating. CMBT was compared to 208 industry peers in the Oil, Gas & Consumable Fuels industry. While CMBT belongs to the best of the industry regarding profitability, there are concerns on its financial health. CMBT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CMBT had positive earnings in the past year.
CMBT had a positive operating cash flow in the past year.
CMBT had positive earnings in 4 of the past 5 years.
CMBT had a positive operating cash flow in 4 of the past 5 years.
CMBT Yearly Net Income VS EBIT VS OCF VS FCFCMBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

Looking at the Return On Assets, with a value of 12.31%, CMBT belongs to the top of the industry, outperforming 89.90% of the companies in the same industry.
CMBT has a Return On Equity of 79.11%. This is amongst the best in the industry. CMBT outperforms 95.67% of its industry peers.
CMBT has a Return On Invested Capital of 5.33%. This is comparable to the rest of the industry: CMBT outperforms 45.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CMBT is significantly below the industry average of 23.39%.
The 3 year average ROIC (9.43%) for CMBT is well above the current ROIC(5.33%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 12.31%
ROE 79.11%
ROIC 5.33%
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.43%
ROIC(5y)N/A
CMBT Yearly ROA, ROE, ROICCMBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

Looking at the Profit Margin, with a value of 72.50%, CMBT belongs to the top of the industry, outperforming 95.67% of the companies in the same industry.
In the last couple of years the Profit Margin of CMBT has grown nicely.
CMBT's Operating Margin of 35.88% is amongst the best of the industry. CMBT outperforms 80.77% of its industry peers.
In the last couple of years the Operating Margin of CMBT has grown nicely.
Looking at the Gross Margin, with a value of 58.65%, CMBT is in the better half of the industry, outperforming 67.31% of the companies in the same industry.
CMBT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 35.88%
PM (TTM) 72.5%
GM 58.65%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
CMBT Yearly Profit, Operating, Gross MarginsCMBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CMBT is creating some value.
The number of shares outstanding for CMBT has been reduced compared to 1 year ago.
The number of shares outstanding for CMBT has been reduced compared to 5 years ago.
CMBT has a worse debt/assets ratio than last year.
CMBT Yearly Shares OutstandingCMBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBT Yearly Total Debt VS Total AssetsCMBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CMBT has an Altman-Z score of 0.64. This is a bad value and indicates that CMBT is not financially healthy and even has some risk of bankruptcy.
CMBT's Altman-Z score of 0.64 is on the low side compared to the rest of the industry. CMBT is outperformed by 62.02% of its industry peers.
A Debt/Equity ratio of 3.75 is on the high side and indicates that CMBT has dependencies on debt financing.
CMBT has a Debt to Equity ratio of 3.75. This is amonst the worse of the industry: CMBT underperforms 87.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Altman-Z 0.64
ROIC/WACC0.71
WACC7.56%
CMBT Yearly LT Debt VS Equity VS FCFCMBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 0.77 indicates that CMBT may have some problems paying its short term obligations.
The Current ratio of CMBT (0.77) is worse than 71.63% of its industry peers.
CMBT has a Quick Ratio of 0.77. This is a bad value and indicates that CMBT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CMBT (0.70) is worse than 67.79% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.7
CMBT Yearly Current Assets VS Current LiabilitesCMBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

CMBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -99.67%.
The Earnings Per Share has been growing by 43.41% on average over the past years. This is a very strong growth
CMBT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.87%.
CMBT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.55% yearly.
EPS 1Y (TTM)-99.67%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-127.37%
Revenue 1Y (TTM)-23.87%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%53.89%

3.2 Future

CMBT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -39.46% yearly.
Based on estimates for the next years, CMBT will show a very strong growth in Revenue. The Revenue will grow by 26.36% on average per year.
EPS Next Y-68.44%
EPS Next 2Y-28.34%
EPS Next 3Y-39.46%
EPS Next 5YN/A
Revenue Next Year35.16%
Revenue Next 2Y30.13%
Revenue Next 3Y26.36%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMBT Yearly Revenue VS EstimatesCMBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CMBT Yearly EPS VS EstimatesCMBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 421.75, the valuation of CMBT can be described as expensive.
70.19% of the companies in the same industry are cheaper than CMBT, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.14. CMBT is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 4.44, the valuation of CMBT can be described as very cheap.
Based on the Price/Forward Earnings ratio, CMBT is valued cheaply inside the industry as 95.67% of the companies are valued more expensively.
CMBT is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 421.75
Fwd PE 4.44
CMBT Price Earnings VS Forward Price EarningsCMBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

CMBT's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.21
CMBT Per share dataCMBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

CMBT has a very decent profitability rating, which may justify a higher PE ratio.
CMBT's earnings are expected to decrease with -39.46% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)9.72
EPS Next 2Y-28.34%
EPS Next 3Y-39.46%

0

5. Dividend

5.1 Amount

CMBT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CMB TECH NV

NYSE:CMBT (8/28/2025, 2:36:08 PM)

8.435

+0.53 (+6.64%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-13 2025-11-13/bmo
Inst Owners1.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.86B
Analysts78
Price Target10.87 (28.87%)
Short Float %5.08%
Short Ratio7.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend5.68
Dividend Growth(5Y)116.35%
DP109.72%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-99.31%
Min EPS beat(2)-149.02%
Max EPS beat(2)-49.61%
EPS beat(4)1
Avg EPS beat(4)9.95%
Min EPS beat(4)-149.02%
Max EPS beat(4)242.1%
EPS beat(8)5
Avg EPS beat(8)86.48%
EPS beat(12)8
Avg EPS beat(12)69.92%
EPS beat(16)10
Avg EPS beat(16)53.9%
Revenue beat(2)1
Avg Revenue beat(2)0.7%
Min Revenue beat(2)-9.81%
Max Revenue beat(2)11.21%
Revenue beat(4)3
Avg Revenue beat(4)5.75%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)15.33%
Revenue beat(8)6
Avg Revenue beat(8)28.28%
Revenue beat(12)10
Avg Revenue beat(12)38.19%
Revenue beat(16)14
Avg Revenue beat(16)43.66%
PT rev (1m)-15.28%
PT rev (3m)-18.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)2.05%
EPS NY rev (3m)2.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)26.15%
Revenue NY rev (3m)26.15%
Valuation
Industry RankSector Rank
PE 421.75
Fwd PE 4.44
P/S 1.33
P/FCF N/A
P/OCF 6.91
P/B 1.45
P/tB 1.7
EV/EBITDA 10.21
EPS(TTM)0.02
EY0.24%
EPS(NY)1.9
Fwd EY22.52%
FCF(TTM)-4.28
FCFYN/A
OCF(TTM)1.22
OCFY14.47%
SpS6.35
BVpS5.82
TBVpS4.96
PEG (NY)N/A
PEG (5Y)9.72
Profitability
Industry RankSector Rank
ROA 12.31%
ROE 79.11%
ROCE 6.75%
ROIC 5.33%
ROICexc 5.45%
ROICexgc 5.6%
OM 35.88%
PM (TTM) 72.5%
GM 58.65%
FCFM N/A
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.43%
ROIC(5y)N/A
ROICexc(3y)10.41%
ROICexc(5y)N/A
ROICexgc(3y)10.46%
ROICexgc(5y)N/A
ROCE(3y)11.93%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.98%
ROICexc growth 3YN/A
ROICexc growth 5Y15.87%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
F-Score2
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Debt/EBITDA 7.03
Cap/Depr 666.34%
Cap/Sales 86.55%
Interest Coverage 3.85
Cash Conversion 39.32%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.7
Altman-Z 0.64
F-Score2
WACC7.56%
ROIC/WACC0.71
Cap/Depr(3y)357.13%
Cap/Depr(5y)252.34%
Cap/Sales(3y)69.97%
Cap/Sales(5y)65.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-99.67%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-127.37%
EPS Next Y-68.44%
EPS Next 2Y-28.34%
EPS Next 3Y-39.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-23.87%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%53.89%
Revenue Next Year35.16%
Revenue Next 2Y30.13%
Revenue Next 3Y26.36%
Revenue Next 5YN/A
EBIT growth 1Y-38.91%
EBIT growth 3YN/A
EBIT growth 5Y15.35%
EBIT Next Year67.95%
EBIT Next 3Y22.95%
EBIT Next 5YN/A
FCF growth 1Y-783.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.61%
OCF growth 3YN/A
OCF growth 5Y11.04%